Effects of Gefitinib on Serum Epidermal Growth Factor Receptor and HER2 in Patients with Advanced Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Effects of Gefitinib on Serum Epidermal Growth Factor Receptor and HER2 in Patients with Advanced Non-Small Cell Lung Cancer

Published:2004-09-15 Issue:18 Volume:10 Page:6006-6012
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Gregorc Vanesa,Ceresoli Giovanni Luca,Floriani Irene,Spreafico Anna,Bencardino Katia Bruna,Ludovini Vienna,Pistola Lorenza,Mihaylova Zhasmina,Tofanetti Francesca Romana,Ferraldeschi Massimiliano,Torri Valter,Cappuzzo Federico,Crinò Lucio,Tonato Maurizio,Villa Eugenio

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “Sandwich” Strategy to Intensify EGFR Blockade by Concurrent Tyrosine Kinase Inhibitor and Monoclonal Antibody Treatment in Highly Selected Patients;Frontiers in Oncology;2022-07-08

2. Prognostic impact of serum levels of EGFR and EGFR ligands in early-stage breast cancer;Scientific Reports;2020-10-06

3. Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER);Annals of Oncology;2020-02

4. EGFR and EGFR ligands in serum in healthy women; reference intervals and age dependency;Clinical Chemistry and Laboratory Medicine (CCLM);2019-07-16

5. Expression and clinical significance of EGF and TGF-α in chronic pancreatitis and pancreatic cancer;Minerva Endocrinology;2018-07